Day-2 Hormonal Profile for Infertility Workup: Reference Ranges and Treatment Algorithms
For infertility evaluation, obtain day-2 hormonal testing including FSH, LH, prolactin, TSH, free T4, estradiol, and AMH, with TSH ideally maintained below 2.5 mIU/L for conception attempts, and treatment decisions based on whether the pattern indicates hypogonadotropic versus hypergonadotropic hypogonadism. 1
Normal Reference Ranges and Interpretation
Day-2 Hormone Levels (Early Follicular Phase)
FSH and LH Patterns:
- Functional Hypothalamic Amenorrhea (FHA): Low or low-normal LH, normal FSH (usually FSH > LH), E2 <50 pg/mL 1
- Hypogonadotropic Hypogonadism: Very low/undetectable FSH and LH (FSH <3.05 IU/L, LH <1.55 IU/L with 92% sensitivity and 94% specificity) 2
- Hypergonadotropic Hypogonadism (Ovarian Insufficiency): Elevated FSH and LH with low E2 (<20 pg/mL); FSH >25 IU/L indicates premature ovarian insufficiency, though levels may range 26-64 IU/L 3, 1
- Normal ovulatory women: FSH 1.3-8.4 IU/L, LH 1.6-8.0 IU/L 4
Prolactin:
- Normal range varies by laboratory
- Levels >100 ng/mL require further evaluation for prolactinoma 1
- Multiple factors transiently elevate prolactin (food, sleep, exercise, breast examination) 1
TSH and Thyroid Function:
- For conception, TSH should be <2.5 mIU/L 5
- The inflection point for optimal ovarian reserve (highest AMH) occurs at TSH 2.88 mIU/L 5
- Elevated TSH with low/low-normal free T4 suggests subclinical or overt hypothyroidism requiring treatment 1
- In FHA, TSH and free T4 are typically in the lower range of normal 1
AMH (Anti-Müllerian Hormone):
- Reflects ovarian reserve and follicle pool
- Very low levels indicate ovarian failure
- AMH remains valid in hypogonadotropic hypogonadism with only negligible underestimation 2
- Wide normal range in healthy young women; age-specific interpretation required 6
TSH Management for Conception
Patients with upper-limit TSH (2.5-4.0 mIU/L) require treatment before conception attempts. The evidence shows:
- TSH levels correlate with ovarian reserve markers (AMH and AFC) 5
- Optimal TSH for fertility is <2.5 mIU/L, not the general population upper limit of 4.0-4.5 mIU/L
- Treat subclinical hypothyroidism with levothyroxine, titrating to TSH <2.5 mIU/L
- Recheck TSH every 4-6 weeks during dose adjustment, then every 3 months once stable
Treatment Algorithms by Diagnosis
Hypogonadotropic Hypogonadism (Low FSH/LH)
First-Line Treatment for Fertility:
Pulsatile GnRH therapy is the gold standard (96% cumulative conception rate after 6 cycles, 29% per-cycle pregnancy rate, only 8.3% multiple gestation rate) 1. However, GnRH is currently unavailable in the United States 1.
When GnRH unavailable, use sequential gonadotropin therapy: 1, 7, 8, 9
Start with hCG monotherapy (mimics LH):
- Provides both LH activity and testosterone production
- Monitor testicular volume and hormone response
- Continue for 3-6 months before adding FSH
Add FSH if inadequate response:
Mandatory luteal phase support:
- hCG injections are ideal to optimize corpus luteum function 8
- Alternative: progesterone supplementation if hCG contraindicated
Clomiphene citrate may be attempted if sufficient endogenous estrogen present (E2 adequate for endometrial response), though success rates are lower 1. A 10-day course may be more effective than standard 5-day protocols 1.
Hypergonadotropic Hypogonadism (Elevated FSH/LH)
There is NO medication to normalize elevated FSH levels in primary ovarian insufficiency. 3, 1
The elevated gonadotropins reflect depleted ovarian reserve—this is the ovary's failure to respond, not a pituitary problem. Treatment options:
- Assisted reproductive technology (ART) with donor oocytes is the primary option
- Spontaneous ovulation occurs in 5-10% of POI cases intermittently—pregnancy is possible but unpredictable 3
- Hormone replacement therapy (HRT) for symptom management and bone/cardiovascular protection, but does NOT restore fertility 3
- No evidence supports FSH-lowering medications, aromatase inhibitors, or other pharmacologic manipulation for improving fertility outcomes in established POI
Elevated Prolactin Management
Treatment depends on prolactin level and etiology: 1
- Prolactin >100 ng/mL: Requires MRI pituitary and specialist evaluation for prolactinoma
- Dopamine agonists (cabergoline or bromocriptine):
- First-line for hyperprolactinemia
- Normalize prolactin levels
- Restore ovulation in most cases
- Cabergoline preferred (better tolerability, twice-weekly dosing)
- Rule out medication-induced hyperprolactinemia (antipsychotics, metoclopramide, etc.)
Elevated FSH/LH Without Clear Hypergonadotropic Pattern
If FSH/LH elevated but E2 >150 pg/mL and progesterone <2 ng/mL: This represents mid-cycle gonadotropin surge, not ovarian failure—repeat testing on day 2-3 of cycle 1
Critical Pitfalls to Avoid
Pattern interpretation is more critical than absolute values 1—a single abnormal value requires confirmation
Oral contraceptives and progestins suppress FSH/LH—discontinue for ≥3 months before retesting 3
Do NOT use testosterone therapy in men or women desiring fertility—it suppresses gonadotropins and worsens infertility 10, 7
Elevated FSH with low E2 (<20 pg/mL) requires GnRH stimulation test to differentiate FHA from organic hypogonadotropic hypogonadism 1
AMH and AFC provide complementary information—use both when available, as AMH correlates with AFC but may be affected by assay variability 6, 2
Morning fasting samples are essential for accurate testosterone and gonadotropin measurement 11
In hypogonadotropic hypogonadism, recombinant FSH alone is insufficient—LH activity (via hCG or hMG) is essential for adequate estradiol response 1
Follow-Up Protocols
For patients with borderline TSH (2.5-4.0 mIU/L):
- Initiate levothyroxine
- Recheck TSH every 4-6 weeks until <2.5 mIU/L
- Once stable, monitor every 3 months during conception attempts
For hypogonadotropic hypogonadism on gonadotropin therapy:
- Monitor follicular development with transvaginal ultrasound every 2-3 days during stimulation
- Measure estradiol levels to assess response and prevent ovarian hyperstimulation
- Cancel cycle if >3 mature follicles develop (multiple pregnancy risk)
For hypergonadotropic hypogonadism:
- Repeat FSH and E2 after 1 month to confirm diagnosis 3
- No benefit to serial FSH monitoring once diagnosis established
- Focus on HRT for symptom management and long-term health